Phase 2 Transplant Patients Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Chidamide Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant.

Ineligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma

Chinese PLA General Hospital100 enrolled1 locationNCT06393361

Recruiting

Phase 1Phase 2

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

E Coli InfectionsAllogenic Transplant Patients

SNIPR Biome Aps.24 enrolled8 locationsNCT06938867

Recruiting

Phase 2

Phase 2 Randomised controlled trial of bone-marrow derived mesenchymal stromal cells (MSC) for new onset chronic lung allograft dysfunction (CLAD)

Lung transplant patients with Chronic Lung Allograph Dysfunction (CLAD)

University of Queensland82 enrolled5 locationsACTRN12616000338460